Purchases and Sales Made in Q2 2025 in Biocryst Pharmaceuticals Inc (BCRX)
This table provides information about the institutional ownership of Biocryst Pharmaceuticals Inc (BCRX) during Q2 2025. The information is specifically focused on institutions that hold shares of BIOCRYST PHARMACEUTICALS INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jul 02, 2025
Q2 2025
|
Doliver Advisors, LP
Houston, TX |
BUY
|
- |
200K+ 269.08% |
$1.28M - $2.24M
|
274K
$2.4M
|
|
Jul 07, 2025
Q2 2025
|
Versant Capital Management, Inc
|
BUY
|
- |
154New |
$987 - $1.72K
|
154
$1.35K
|
|
Jul 07, 2025
Q2 2025
|
Parallel Advisors, LLC
|
SELL
|
- |
-43- 31.62% |
$276 - $481
|
93
$815
|